glp-1 receptor agonist examples Agonists as Treatments for Type 2 Diabetes Discovery of GLP-1–Based Drugs for

72 , 73 A large international cohort study across six population-based databases compared nearly 100,000 GLP-1 RA users to over 2.4 million dipeptidyl peptidase-4 (DPP-4) inhibitor users and found no evidence of increased thyroid cancer risk (pooled weighted HR: 0.81, 95% CI 0.59, 1.12)

Treatment with liraglutide--a once-daily GLP-1 analog--does not reduce the bioavailability of ethinyl estradiol/levonorgestrel taken as an oral combination contraceptive drug

[86] found that semaglutide, as a GLP-1 analog, can directly act on fat cells, increase the expression of thermogenic genes for browning phenotype maintenance, improve the expression of UCP1, mitochondrial biosynthesis and thermogenic marker, thereby contributing to weight loss

289 The rise in cAMP activates PKA, a versatile protein kinase that phosphorylates various target proteins

Results of randomized trials Six large randomized trials and a post hoc analysis 1521 have investigated the safety and efficacy of GLP-1 receptor agonists in patients with type 2 diabetes who also either had known cardiovascular disease or were at high risk of it, using a composite of major adverse cardiovascular events (myocardial infarction, stroke, or death from cardiovascular causes) as the primary end point (Table 2)

August 6 , 2024: Judge Marston Issues Detailed Discovery Order in Ozempic Lawsuit Judge Marston has issued a thorough discovery order in the Ozempic Lawsuit